[DOI] [PMC free article] [PubMed] [Google Scholar] 325.Sugiyama T., Kugimiya F., Kono S., Kim Y.T., Oda H
Study finds yet another use for popular diabetes and obesity drugs Several new uses have been found for the drugs Bookmark CommentsGo to comments Popular obesity drugs, such as Ozempic, could also help to protect the kidneys, a new study has suggested
95% CI 0.56, 0.12), GLP-1 RAs/metformin (WMD: 0.23
Much like the recent addition of heart disease as a condition these GLP-1s can treat, research is informing additional conditions for which these drugs are indicated
doi: 10.3390/antiox11071279 44
Research has demonstrated that metabolic disease models are frequently associated with altered NAD+ metabolism, with studies showing reduced NAD+ levels in animal models of type 2 diabetes, obesity, and metabolic syndrome